Intertumoral Heterogeneity within Medulloblastoma Subgroups
Cavalli, Florence M.G., Remke, Marc, Rampasek, Ladislav, Peacock, John, Shih, David J.H., Luu, Betty, Garzia, Livia, Torchia, Jonathon +87 more·2017·Cancer Cell
Cited by (1,000)
Items 301–400 of 1,000
- Cellular immunotherapy for medulloblastomaMichael Y. Schakelaar, Matthijs Monnikhof, Sandra Crnko, Emma W Pijnappel, Jan Meeldijk, Toine ten Broeke, Niels Bovenschen · 2022 · Neuro-Oncology
- Precision Medicine in Pediatric Neurooncology: A ReviewAaron Y. Mochizuki, Isaura M. Frost, Melina B. Mastrodimos, Ashley Plant, Anthony Wang, Theodore Bruce Moore, Robert Michael Prins, Paul S. Weiss, Steven John Jonas · 2017 · ACS Chemical Neuroscience
- Molecular characterization of medulloblastomas with extensive nodularity (MBEN)Andrey Korshunov, Felix Sahm, Damian Stichel, Daniel Schrimpf, Marina Vladimirovna Ryzhova, Olga Zheludkova, Андрей Владимирович Голанов, Peter Lichter, David Jones, Andreas von Deimling et al. · 2018 · Acta Neuropathologica
- In silico analysis of long non-coding RNAs in medulloblastoma and its subgroupsPiyush K. Joshi, George I. Jallo, Ranjan Joseph Perera · 2020 · Neurobiology of Disease
- MethylSPWNet and MethylCapsNet: Biologically Motivated Organization of DNAm Neural Networks, Inspired by Capsule NetworksJoshua Levy, Youdinghuan Chen, Nasim Azizgolshani, Curtis Lee Petersen, Alexander Titus, Erika L. Moen, Louis Joseph Vaickus, Lucas A. Salas, Brock C. Christensen · 2021 · npj Systems Biology and Applications
- The AHR pathway represses TGFβ-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastomaNemanja Sarić, Matthew P. Selby, Vijay Ramaswamy, Marcel Kool, Brigitta Stockinger, Christer Högstrand, Daniel Williamson, Silvia Marino, Michael D. Taylor, Steven C. Clifford et al. · 2020 · Scientific Reports
- Extracellular vesicle-associated miR-135b and -135a regulate stemness in Group 4 medulloblastoma cells by targeting angiomotin-like 2Seung Ah Choi, Eun Jung Koh, Ryong Nam Kim, Jung Woo Byun, Ji Hoon Phi, Jeyul Yang, Kyu‐Chang Wang, Ae Kyung Park, Do Won Hwang, Ji Yeoun Lee et al. · 2020 · Cancer Cell International
- Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges AheadSumana Shrestha, Alaide Morcavallo, Chiara Gorrini, Louis Chesler · 2021 · Frontiers in Oncology
- Childhood Medulloblastoma: An OverviewYujin Suk, William D. Gwynne, Ian Burns, Chitra Venugopal, Sheila Kumari Singh · 2022 · Methods in molecular biology
- TOP2A correlates with poor prognosis and affects radioresistance of medulloblastomaYufeng Zhang, Haiyan Yang, Liwen Wang, Huandi Zhou, Ge Zhang, Zhiqing Xiao, Xiaoying Xue · 2022 · Frontiers in Oncology
- A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) MedulloblastomaMatthew J. Kling, Varun Kesherwani, Nitish K. Mishra, Gracey R. Alexander, Erin M. McIntyre, Sutapa Ray, Kishore B. Challagundla, Shantaram S. Joshi, Donald W. Coulter, Nagendra K. Chaturvedi · 2022 · Journal of Experimental & Clinical Cancer Research
- Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, Dominik Sturm, Katja Kloth‐Stachnau, Florian Selt, Jonas Ecker, Katja von Hoff, Björn-Ole Juhnke, Tobias Goschzik et al. · 2022 · Acta Neuropathologica
- Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog MedulloblastomaM. Hope Robinson, Victor D Maximov, Shoeb B. Lallani, Hamza Farooq, Michael D. Taylor, Renee D Read, Anna Marie Kenney · 2019 · Scientific Reports
- Embryonal Tumors of the Central Nervous SystemMelissa M. Blessing, Sanda Alexandrescu · 2020 · Surgical pathology clinics
- Medulloblastoma: an Old Diagnosis with New PromisesLuca Szalontay, Yasmin Khakoo · 2020 · Current Oncology Reports
- Long non-coding RNAs in brain tumorsKeisuke Katsushima, George I. Jallo, Charles G. Eberhart, Ranjan Joseph Perera · 2021 · NAR Cancer
- Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumorsLuca Bertero, Luca Mangherini, Alessia Andrea Ricci, Paola Cassoni, Felix Sahm · 2023 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
- Oncogene aberrations drive medulloblastoma progression, not initiationKonstantin Okonechnikov, Piyush K. Joshi, Verena Körber, Anne Rademacher, Michele Bortolomeazzi, Jan‐Philipp Mallm, Jan Vaillant, Patricia Benites Goncalves da Silva, Britta Statz, Mari Sepp et al. · 2025 · Nature
- Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatmentAnna Briel-Pump, Thomas Beez, Lara Ebbert, Marc Remke, Sandra Weinhold, Michael Sabel, Rüdiger V. Sorg · 2018 · Journal of Photochemistry and Photobiology B Biology
- Pediatric embryonal brain tumors in the molecular eraBryan K. Li, Salma A. Al-Karmi, Annie Huang, Éric Bouffet · 2020 · Expert Review of Molecular Diagnostics
- A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven MedulloblastomaDong Wang, Angela M. Pierce, Bethany L. Veo, Susan P. Fosmire, Etienne P. Danis, Andrew M. Donson, Sujatha Venkataraman, Rajeev Vibhakar · 2021 · Cancers
- DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic markerNasim Azizgolshani, Curtis Lee Petersen, Youdinghuan Chen, Joshua Levy, Lucas A. Salas, Laurent Perreard, Lananh Nguyen, Brock C. Christensen · 2021 · Clinical Epigenetics
- Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatinSatoshi Nakata, Junko Murai, Masayasu Okada, Haruhiko Takahashi, Tyler Findlay, Kristen J. Malebranche, Akhila Parthasarathy, Satoshi Miyashita, Ramil Gabdulkhaev, Ilan Benkimoun et al. · 2022 · Neuro-Oncology
- Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imagingFranziska Linke, James E. C. Johnson, Stefanie Kern, Christopher Bennett, Anbarasu Lourdusamy, Daniel Lea, Steven C. Clifford, Catherine L.R. Merry, Snow Stolnik, Morgan R. Alexander et al. · 2023 · Acta Neuropathologica Communications
- The Neurodevelopmental and Molecular Landscape of Medulloblastoma Subgroups: Current Targets and the Potential for Combined TherapiesHasan Slika, Paolo Alimonti, Divyaansh Raj, Chad A. Caraway, Safwan Alomari, Eric M. Jackson, Betty Tyler · 2023 · Cancers
- Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179Yuchen Li, Chaemin Lim, Taylor Dismuke, Daniel Shiloh Malawsky, Sho Oasa, Zara C. Bruce, Carolin Offenhäuser, Ulrich Baumgartner, Rochelle C. J. D’Souza, Stacey L. Edwards et al. · 2025 · Nature Communications
- Low Expression of miR-466f-3p Sustains Epithelial to Mesenchymal Transition in Sonic Hedgehog Medulloblastoma Stem Cells Through Vegfa-Nrp2 Signaling PathwayZein Mersini Besharat, Claudia Sabato, Agnese Pò, Francesca Gianno, Luana Abballe, Maddalena Napolitano, Evelina Miele, Felice Giangaspero, Alessandra Vacca, Giuseppina Catanzaro et al. · 2018 · Frontiers in Pharmacology
- Molecular Genetics of Medulloblastoma in Children: Diagnostic, Therapeutic and Prognostic ImplicationsMaher El Doussouki, Amar J. Gajjar, Omar Chamdine · 2019 · Future Neurology
- TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastomaMalte Hellwig, Marlen C. Lauffer, Michael Ludwig Bockmayr, Michael Spohn, Daniel J. Merk, Luke Harrison, Julia Ahlfeld, Annabel Kitowski, Julia E. Neumann, Jasmin Ohli et al. · 2019 · Acta Neuropathologica
- Sonic hedgehog accelerates DNA replication to cause replication stress promoting cancer initiation in medulloblastomaLukas Tamayo-Orrego, David Gallo, Frédéric Racicot, Amandine Bemmo, Sushmetha Mohan, Brandon Ho, Samer Salameh, T Hoang, Andrew P. Jackson, Grant W. Brown et al. · 2020 · Nature Cancer
- Identification of a Twelve-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival for MedulloblastomaSihan Zhu, Fuhua Lin, Zhenghe Chen, Xiaobing Jiang, Ji Zhang, Qunying Yang, Yinsheng Chen, Jian Wang · 2020 · Frontiers in Genetics
- Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cellsMarta Buzzetti, Sonia Morlando, Dimitrios Solomos, Ammara Mehmood, Alexander W. I. Cox, Mattia Chiesa, Yuri D’Alessandra, Michela Garofalo, Caroline H. Topham, Gianpiero Di Leva · 2021 · Scientific Reports
- Development of Randomized Trials in Adults with Medulloblastoma—The Example of EORTC 1634-BTG/NOA-23Peter Hau, Didier Frappaz, Elizabeth Jane Hovey, Martin G. McCabe, Kristian W. Pajtler, Benedikt Wiestler, Clemens Seidel, Stephanie Elisabeth Combs, Linda Dirven, Martin Klein et al. · 2021 · Cancers
- GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of SubtypeClaudia Paret, Arsenij Ustjanzew, Sara Ersali, Larissa Seidmann, Richard Jennemann, Nicole Ziegler, Khalifa El Malki, Alexandra Russo, Arthur Wingerter, Franziska Ortmüller et al. · 2022 · Cancers
- Network medicine for patients' stratification: From single‐layer to multi‐omicsManuela Petti, Lorenzo Farina · 2023 · WIREs Mechanisms of Disease
- Identification of Two Protein-Signaling States Delineating Transcriptionally Heterogeneous Human MedulloblastomaWalderik W. Zomerman, Sabine L. A. Plasschaert, Siobhan Conroy, Frank J.G. Scherpen, Tiny Meeuwsen-de Boer, Harm Jan Lourens, Sergi Guerrero Llobet, Marlinde J. Smit, Lorian Slagter‐Menkema, Annika Seitz et al. · 2018 · Cell Reports
- Epigenetic cerebellar diseasesMercedes Serrano · 2018 · Handbook of clinical neurology
- BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression LanguageCharles Tapley Hoyt, Daniel Domingo‐Fernándéz, Martin Hofmann‐Apitius · 2018 · Database
- CITK Loss Inhibits Growth of Group 3 and Group 4 Medulloblastoma Cells and Sensitizes Them to DNA-Damaging AgentsGianmarco Pallavicini, Giorgia Iegiani, Gaia Elena Berto, Elisa Calamia, Edoardo Trevisiol, Andrea Veltri, Simona Allis, Ferdinando Di Cunto · 2020 · Cancers
- Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastomaXiaohua Liu, Yu Zhang, Yalei Li, Juan Wang, Huaqian Ding, Wenjing Huang, Chunyong Ding, Hong‐Chun Liu, Wenfu Tan, Ao Zhang · 2020 · Acta Pharmaceutica Sinica B
- Real-time sensing of MAPK signaling in medulloblastoma cells reveals cellular evasion mechanism counteracting dasatinib blockade of ERK activation during invasionMarc Thomas Schönholzer, Jessica Migliavacca, Elena Alvarez, Karthiga Santhana Kumar, Anuja Neve, Alexandre Gries, Min Ma, Michael Andreas Grotzer, Martin Baumgartner · 2020 · Neoplasia
- EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain TumorsBárbara Kunzler Souza, Natália Hogetop Freire, Mariane da Cunha Jaeger, Caroline Brunetto de Farias, Algemir Lunardi Brunetto, Andre Tesainer Brunetto, Rafael Roesler · 2021 · International Journal of Molecular Sciences
- Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 StudyChristine Gaab, Jonas E Adolph, Stephan Tippelt, Ruth Mikasch, Denise Obrecht, Martin Mynarek, Stefan Rutkowski, Stefan Michael Pfister, Till Milde, Olaf Witt et al. · 2022 · Cancers
- Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical modelsJezabel Rodríguez‐Blanco, April Salvador, Robert K. Suter, Marzena Swiderska‐Syn, Isabel Palomo-Caturla, Valentin M. Kliebe, Pritika H. Shahani, Kendell D. Peterson, María Turos‐Cabal, Megan E. Vieira et al. · 2024 · Journal of Clinical Investigation
- Sterol regulation of developmental and oncogenic Hedgehog signalingVikas Daggubati, David Ronan Raleigh, Navdar Sever · 2021 · Biochemical Pharmacology
- Immune cell landscape and immunotherapy of medulloblastomaJin Zhang, Tianyou Wang · 2021 · Pediatric Investigation
- Noncanonical activation of GLI signaling in SOX2 + cells drives medulloblastoma relapseMarzena Swiderska‐Syn, Júlia Mir-Pedrol, Alexander R. Oles, Olga Schleuger, April Salvador, Sean M. Greiner, Cara Seward, Fan Yang, Benjamin R. Babcock, Chen Shen et al. · 2022 · Science Advances
- SADLN: Self-attention based deep learning network of integrating multi-omics data for cancer subtype recognitionQiuwen Sun, Lei Cheng, Ao Meng, Shuguang Ge, Jie Chen, Longzhen Zhang, Ping Gong · 2023 · Frontiers in Genetics
- Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibitionTuan Vo, Brad Balderson, Kahli Jones, Guiyan Ni, Joanna Crawford, Amanda Millar, Elissa Tolson, Matthew Singleton, Onkar Mulay, Shaun B. Walters et al. · 2023 · Genome Medicine
- The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastomaPiyush K. Joshi, Keisuke Katsushima, Rui Zhou, Avner Meoded, Stacie L. Stapleton, George I. Jallo, Eric H. Raabe, Charles G. Eberhart, Ranjan Joseph Perera · 2019 · Neuro-Oncology Advances
- Expression of GNAS, TP53, and PTEN Improves the Patient Prognostication in Sonic Hedgehog (SHH) Medulloblastoma SubgroupLuciane Sussuchi da Silva, Bruna Minniti Mançano, Flávia Escremim de Paula, Mariana Bisarro dos Reis, Gisele Caravina de Almeida, Marcus De Medeiros Matsushita, Antônio Carlos, Adriane Feijó Evangelista, Fabiano Pinto Saggioro, Luciano Neder Serafini et al. · 2020 · Journal of Molecular Diagnostics
- Statins repress hedgehog signaling in medulloblastoma with no bone toxicitiesQianhai Fan, Tingting Gong, Chaonan Zheng, Jessica M.Y. Ng, Jianquan Chen, Cynthia B. Myers, Harvey H. Hensley, Tom Curran, Zeng-jie Yang · 2021 · Oncogene
- Infant medulloblastoma — learning new lessons from old strataMarc Remke, Vijay Ramaswamy · 2018 · Nature Reviews Clinical Oncology
- Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in MedulloblastomaAmanda Thomaz, Kelly de Vargas Pinheiro, Bárbara Kunzler Souza, Lauro José Gregianin, Algemir Lunardi Brunetto, Andre Tessainer Brunetto, Caroline Brunetto de Farias, Mariane da Cunha Jaeger, Vijay Ramaswamy, Carolina Nör et al. · 2019 · Frontiers in Pharmacology
- REST promotes ETS1‐dependent vascular growth in medulloblastomaShavali Shaik, Shinji Maegawa, Amanda R. Haltom, Feng Wang, Xue Xiao, Tara Dobson, Ajay Sharma, Yanwen Yang, Jyothishmathi Swaminathan, Vikas Kundra et al. · 2021 · Molecular Oncology
- Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastomaEmma Martell, Helgi Kuzmychova, Esha Kaul, Harshal Senthil, Subir Roy Chowdhury, Ludivine Coudière Morrison, Agnes L. Fresnoza, Jamie L. Zagozewski, Chitra Venugopal, Christopher M. Anderson et al. · 2023 · Nature Communications
- Recent advances in SHH medulloblastoma progression: tumor suppressor mechanisms and the tumor microenvironmentLukas Tamayo-Orrego, Frédéric Charron · 2019 · F1000Research
- A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) MedulloblastomaNagendra K. Chaturvedi, Matthew J. Kling, Connor N. Griggs, Varun Kesherwani, Mamta Shukla, Erin M. McIntyre, Sutapa Ray, Yutong Liu, Timothy R. McGuire, John Graham Sharp et al. · 2020 · Molecular Cancer Therapeutics
- 3D hydrogels reveal medulloblastoma subgroup differences and identify extracellular matrix subtypes that predict patient outcomeFranziska Linke, Macha Aldighieri, Anbarasu Lourdusamy, Anna M. Grabowska, Snow Stolnik, Ian Derek Kerr, Catherine L.R. Merry, Beth Coyle · 2020 · The Journal of Pathology
- Adolescent and young adult neuro-oncology: a comprehensive reviewKee Kiat Yeo, Darcy E. Burgers, Katelynn Brodigan, Karen M. Fasciano, A. Lindsay Frazier, Katherine E. Warren, David A. Reardon · 2021 · Neuro-Oncology Practice
- Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastomaVictor Pereira, Jacob Torrejon-Diaz, Dulanjalee Kariyawasam, Pablo Berlanga, Léa Guerrini‐Rousseau, Olivier Ayrault, Pascale Varlet, Arnault Tauziède‐Espariat, Stéphanie Puget, Stéphanie Bolle et al. · 2021 · Neuro-Oncology Advances
- Genomics Paves the Way for Better Infant Medulloblastoma TherapyGiles W Robinson, Amar J. Gajjar · 2020 · Journal of Clinical Oncology
- Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activationJulian Bryan Iorgulescu, Jessica Van Ziffle, Meredith Stevers, James P. Grenert, Boris C. Bastian, Lukas Chávez, Damian Stichel, Ivo Buchhalter, David Samuel, Theodore P. Nicolaides et al. · 2018 · Acta Neuropathologica
- Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progressionJamie L. Zagozewski, Stephanie Borlase, Brent J. Guppy, Ludivine Coudière-Morrison, Ghazaleh M. Shahriary, Victor Dela Gordon, Lisa Liang, Stephen Cheng, Christopher J. Porter, Rhonda Kelley et al. · 2022 · Communications Biology
- Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kineticsJia‐Wei Lv, Chen‐Fei Wu, Junyan Li, Fo‐Ping Chen, Shiwei He, Qing‐Mei He, Guan‐Qun Zhou, Jun Ma, Ying Hao Sun, Denghui Wei et al. · 2022 · BMC Medicine
- Miat and interacting protein Metadherin maintain a stem-like niche to promote medulloblastoma tumorigenesis and treatment resistanceKai-Lin Peng, Harish N. Vasudevan, Dennis Timothy Lockney, Rachel Baum, Ronald C. Hendrickson, David Ronan Raleigh, Adam M. Schmitt · 2022 · Proceedings of the National Academy of Sciences
- Pediatric Brain Tumors in the Molecular Era: Updates for the RadiologistJehan AlRayahi, Osamah Alwalid, Walid Mabrouk Mubarak, Ata Ur Rehman Maaz, William Mifsud · 2022 · Seminars in Roentgenology
- ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumorsOliver J. Mainwaring, Holger Weishaupt, Miao Zhao, Gabriela Rosén, Anna Borgenvik, Laura Breinschmid, Annemieke D. Verbaan, Stacey Richardson, Dean Thompson, Steven C. Clifford et al. · 2023 · Nature Communications
- Brain Tumor Imaging in Adolescents and Young Adults: 2021 WHO Updates for Molecular-based Tumor TypesMatthias W Wagner, Pejman Jabehdar Maralani, Julie Bennett, Liana Figueiredo Nobre, Mary Jane Lim-Fat, Peter B. Dirks, Suzanne Laughlin, Uri Y. Tabori, Vijay Ramaswamy, Cynthia E Hawkins et al. · 2024 · Radiology
- Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cellsSophie J. Cowman, Yuen Ngan Fan, Barry L. Pizer, Violaine Sée · 2019 · BMC Cancer
- Simplified Molecular Subtyping of Medulloblastoma for Reduced Cost and Improved Turnaround TimeSomruetai Shuangshoti, Paveen Tadadontip, Piti Techavichit, Paul Scott Thorner, Shanop Shuangshoti, Chinachote Teerapakpinyo · 2019 · Applied immunohistochemistry & molecular morphology
- CENPE Inhibition Leads to Mitotic Catastrophe and DNA Damage in Medulloblastoma CellsGiorgia Iegiani, Marta Gai, Ferdinando Di Cunto, Gianmarco Pallavicini · 2021 · Cancers
- Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against MedulloblastomaMarina Pagnuzzi‐Boncompagni, Vincent Picco, Valérie Vial, Vı́ctor Planas-Bielsa, Ashaina Vandenberghe, Thomas Daubon, Marie‐Alix Derieppe, Christopher Montemagno, Jérôme Durivault, Renaud Grépin et al. · 2021 · Cancers
- Cooperation of Striatin 3 and MAP4K4 promotes growth and tissue invasionJessica Migliavacca, Buket Züllig, Charles Capdeville, Michael Andreas Grotzer, Martin Baumgartner · 2022 · Communications Biology
- Diagnostic Accuracy of a Reduced Immunohistochemical Panel in Medulloblastoma Molecular Subtyping, Correlated to DNA-methylation AnalysisArnault Tauziède‐Espariat, Sophie Huybrechts, Émilie Indersie, Christelle Dufour, Stéphanie Puget, Anaïs Chivet, Alexandre Roux, Mélanie Pagès, Albane Gareton, Fabrice C Chrétien et al. · 2020 · The American Journal of Surgical Pathology
- Notch1 switches progenitor competence in inducing medulloblastomaClaudio Ballabio, Matteo Gianesello, Chiara Lago, Konstantin Okonechnikov, Marica Anderle, Giuseppe Aiello, Francesco Antonica, Tingting Zhang, Francesca Gianno, Felice Giangaspero et al. · 2021 · Science Advances
- DNA methylation alterations across time and space in paediatric brain tumoursAnna Wenger, Sandra Ferreyra Vega, Elizabeth Schepke, Maja Löfgren, Thomas Olsson Bontell, Magnus Tisell, Daniel T. Nilsson, Teresia Kling, Helena Carén · 2022 · Acta Neuropathologica Communications
- Exploring the Molecular Complexity of Medulloblastoma: Implications for Diagnosis and TreatmentJulian S. Rechberger, Stephanie A. Toll, Wouter J. F. Vanbilloen, David J. Daniels, Soumen Khatua · 2023 · Diagnostics
- The Nervous System Development Regulator Neuropilin-1 as a Potential Prognostic Marker and Therapeutic Target in Brain CancerEduardo Mello Rodrigues, Allan Fernando Giovanini, Carmen Austrália Paredes Marcondes Ribas, Osvaldo Malafaia, Rafael Roesler, Gustavo Rassier Isolan · 2023 · Cancers
- Desmoplastic nodular medulloblastoma in young children: a management dilemmaMohamed Shebl Abdelbaki, Daniel R. Boué, Jonathan L. Finlay, Mark W. Kieran · 2017 · Neuro-Oncology
- Decoding Somatic Driver Gene Mutations and Affected Signaling Pathways in Human Medulloblastoma SubgroupsCharles T. Robbins, Mayassa J. Bou-Dargham, Kevin G. Sanchez, Matthew C. Rosen, Qing‐Xiang Amy Sang · 2018 · Journal of Cancer
- Crosstalk between SHH and FGFR Signaling Pathways Controls Tissue Invasion in MedulloblastomaAnuja Neve, Jessica Migliavacca, Charles Capdeville, Marc Thomas Schönholzer, Alexandre Gries, Min Ma, Karthiga Santhana Kumar, Michael Andreas Grotzer, Martin Baumgartner · 2019 · Cancers
- Proteome and miRNome profiling of microvesicles derived from medulloblastoma cell lines with stem-like properties reveals biomarkers of poor prognosisCarolini Kaid, Amanda F. Assoni, Marina Marçola, Patrícia Semedo, Raul Hernandes Bortolin, Valdemir Melechco Carvalho, Oswaldo Keith Okamoto · 2020 · Brain Research
- Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabineDaniel C. Moreira, Sujatha Venkataraman, Apurva Subramanian, John A. DeSisto, Ilango Balakrishnan, Eric W. Prince, Angela M. Pierce, Andrea M. Griesinger, Adam Green, Charles G. Eberhardt et al. · 2020 · Journal of Neuro-Oncology
- Molecular subgrouping of medulloblastoma based on few-shot learning of multitasking using conventional MR images: a retrospective multicenter studyXi Chen, Zhen Fan, Kay Ka‐Wai Li, Guoqing Wu, Zhong Hui Yang, Xin Gao, Yingchao Liu, Haibo Wu, Hong Chen, Qisheng Tang et al. · 2020 · Neuro-Oncology Advances
- YBX1 Indirectly Targets Heterochromatin-Repressed Inflammatory Response-Related Apoptosis Genes through Regulating CBX5 mRNAAndreas Kloetgen, Sujitha Duggimpudi, K Schuschel, Kebria Hezaveh, Daniel J. Picard, Heiner Schaal, Marc Remke, Jan‐Henning Klusmann, Arndt Borkhardt, Alice Carolyn McHardy et al. · 2020 · International Journal of Molecular Sciences
- VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cellsManon Penco-Campillo, Yannick Comoglio, Álvaro Javier Feliz Morel, Rita A. Hanna, Jérôme Durivault, Magalie Leloire, Bastien Mejias, Marina Pagnuzzi, Amandine Morot, Fanny Burel‐Vandenbos et al. · 2020 · Communications Biology
- Inter and intra-tumoral heterogeneity as a platform for personalized therapies in medulloblastomaMarina Danilenko, Steven C. Clifford, Ed C. Schwalbe · 2021 · Pharmacology & Therapeutics
- Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growthKarthiga Santhana Kumar, Cyrill Brunner, Matthias Schuster, Levi Luca Kopp, Alexandre Gries, Yan Shen, Simon Jurt, Kerstin Moehle, Dominique Bruns, Michael Andreas Grotzer et al. · 2022 · Cellular Oncology
- Hedgehog pathway, cell cycle, and primary ciliumTenghan Zhuang · 2025 · Cell Death Discovery
- Current Strategies for Management of MedulloblastomaMichael D. Prados · 2023 · Diagnostics
- Lipidomic-Based Approach to 10 s Classification of Major Pediatric Brain Cancer Types with Picosecond Infrared Laser Mass SpectrometryMichael Woolman, Taira Kiyota, Siham Amara-Belgadi, Naohide Fujita, Alexa Fiorante, Vijay Ramaswamy, Craig E Daniels, James T. Rutka, Chris McIntosh, David G. Muñoz et al. · 2024 · Analytical Chemistry
- Sonic Hedgehog Medulloblastoma Cancer Stem Cells Mirnome and Transcriptome Highlight Novel Functional NetworksAgnese Pò, Luana Abballe, Claudia Sabato, Francesca Gianno, Martina Chiacchiarini, Giuseppina Catanzaro, Enrico De Smaele, Felice Giangaspero, Elisabetta Ferretti, Evelina Miele et al. · 2018 · International Journal of Molecular Sciences
- Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhoodSimone Minasi, Caterina Baldi, Torsten Pietsch, Vittoria Donofrio, Bianca Pollo, Manila Antonelli, Maura Massimino, Felice Giangaspero, Francesca Romana Buttarelli · 2019 · Journal of Neuro-Oncology
- Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastomaKathleen M. Schieffer, Elizabeth Varga, Katherine E. Miller, Vibhuti Agarwal, Daniel C. Koboldt, Patrick Joseph Brennan, Benjamin Kelly, Ashita Dave‐Wala, Christopher R. Pierson, Jonathan L. Finlay et al. · 2019 · European Journal of Medical Genetics
- Medulloblastoma epigenetics and the path to clinical innovationAmanda R. Haltom, Stephanie A. Toll, Donghang Cheng, Shinji Maegawa, Vidya Gopalakrishnan, Soumen Khatua · 2020 · Journal of Neuro-Oncology
- Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profileDaniel Shiloh Malawsky, Seth Weir, Jennifer Karin Ocasio, Benjamin R. Babcock, Taylor Dismuke, Abigail H. Cleveland, Andrew M. Donson, Rajeev Vibhakar, Kirk C. Wilhelmsen, Timothy R. Gershon · 2021 · Communications Biology
- Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and ChallengesBo Qiu, Cassie Kline, Sabine Mueller · 2021 · Frontiers in Oncology
- Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastomaSara Badodi, Nicola Pomella, Yau Mun Lim, Sebastian Brandner, Gillian M. Morrison, Steven M. Pollard, Xinyu Zhang, Nicolae Radu Zabet, Silvia Marino · 2022 · Neuro-Oncology
- Whole-genome sequencing of extrachromosomal circular DNA of cerebrospinal fluid of medulloblastomaYi Zhu, Zhihui Liu, Yuduo Guo, Shenglun Li, Yanming Qu, Lin Dai, Yujia Chen, Weihai Ning, Hongwei Zhang, Lixin Ma · 2022 · Frontiers in Oncology